Statements and press releases

Monday 23rd  October 2017 Government moves to reclassify pain medications pregabalin and gabapentin create  fear and anxiety for people living with long-term pain Health charity Pain Concern is warning that moves to restrict prescribed painkillers pregabalin and gabapentin over their

We at Pain Concern wish to address the recent articles published in Pulse Today titled ‘Pregabalin and gabapentine set to become controlled drugs’ on the 21st September, and the British Medical Journal (BMJ) on the 25th September 2017 titled ‘UK government to reclassify pregabalin and

Pain Concern is a national charity that supports those who live with long term pain, and those who care for them, by providing information on pain and its management through a variety of media platforms. We also raise awareness about pain and the need to improve the provision of pain

Pain Concern supports the following press release from the Royal College of Anaesthetists and the Faculty of Pain Medicine  “Response to recent news reports regarding fentanyl “The Royal College of Anaesthetists (RCoA) and The Faculty of Pain Medicine (FPM) are concerned with misinfor

Pain Concern has described as “deeply regrettable” a decision by NHS England to deprive chronic pain patients of access to two specialist treatments. The decision means that chronic pain patients will no longer be eligible for deep brain stimulation and intrathecal drug delivery in th

Airing Pain, the popular digital radio programme for people living with chronic pain, is returning for a brand new series

As a survey of UK drug use reveals a ‘significant increase in misuse’ of two of the most important drugs for chronic pain, pregabalin and gabapentin, Pain Concern is urging prescribers to ensure that these often life-changing treatments remain available to people living with pain. The

A new joint campaign is set to offer self-management advice and information to people living with chronic pain.